These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Leroi I; Brandt J; Reich SG; Lyketsos CG; Grill S; Thompson R; Marsh L Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693 [TBL] [Abstract][Full Text] [Related]
11. Responses to donepezil in Alzheimer's disease and Parkinson's disease. Mori S Ann N Y Acad Sci; 2002 Nov; 977():493-500. PubMed ID: 12480791 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of dementia with Lewy bodies. Josif S; Graham K JAAPA; 2008 May; 21(5):22-6. PubMed ID: 18556885 [No Abstract] [Full Text] [Related]
13. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine. Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665 [TBL] [Abstract][Full Text] [Related]
14. AD2000: donepezil in Alzheimer's disease. Schneider LS Lancet; 2004 Jun; 363(9427):2100-1. PubMed ID: 15220027 [No Abstract] [Full Text] [Related]
15. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Rodda J; Morgan S; Walker Z Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824 [TBL] [Abstract][Full Text] [Related]
16. Rosmarinic acid protects against chronic ethanol-induced learning and memory deficits in rats. Hasanein P; Seifi R; Hajinezhad MR; Emamjomeh A Nutr Neurosci; 2017 Nov; 20(9):547-554. PubMed ID: 27367870 [TBL] [Abstract][Full Text] [Related]
17. [Tacrine]. Dávila C; Viteri C; de Castro P Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715 [TBL] [Abstract][Full Text] [Related]